These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20973771)

  • 41. Etanercept for psoriasis in the pediatric population: experience in nine patients.
    Hawrot AC; Metry DW; Theos AJ; Levy ML
    Pediatr Dermatol; 2006; 23(1):67-71. PubMed ID: 16445417
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety and efficacy study on etanercept in patients with plaque psoriasis.
    Costanzo A; Mazzotta A; Papoutsaki M; Nisticò S; Chimenti S
    Br J Dermatol; 2005 Jan; 152(1):187-9. PubMed ID: 15656833
    [No Abstract]   [Full Text] [Related]  

  • 43. Acitretin narrow-band TL-01 phototherapy but not etanercept treatment improves a localized inflammatory linear verrucous epidermal naevus with concomitant psoriasis.
    Ozdemir M; Mevlitoğlu I; Balevi A
    J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1453-4. PubMed ID: 19470068
    [No Abstract]   [Full Text] [Related]  

  • 44. Etanercept treatment in myasthenia gravis.
    Rowin J
    Ann N Y Acad Sci; 2008; 1132():300-4. PubMed ID: 18567881
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Risks and side effect reactions during therapy with TNF-alpha blockers. An immunologic analysis].
    Berg PA
    Dtsch Med Wochenschr; 2004 Jul; 129(30):1631-4. PubMed ID: 15257503
    [No Abstract]   [Full Text] [Related]  

  • 46. BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology.
    Keat A; Barkham N; Bhalla A; Gaffney K; Marzo-Ortega H; Paul S; Rogers F; Somerville M; Sturrock R; Wordsworth P;
    Rheumatology (Oxford); 2005 Jul; 44(7):939-47. PubMed ID: 15901904
    [No Abstract]   [Full Text] [Related]  

  • 47. Etanercept in psoriasis treatment.
    Pietrzak A; Chodorowska G; Urban J; Roliński J; Pietrzak B
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):222-6. PubMed ID: 15314989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Peripheral mononeuropathy with etanercept use: case report.
    Hanaoka BY; Libecco J; Rensel M; Hajj-Ali RA
    J Rheumatol; 2008 Jan; 35(1):182. PubMed ID: 18176996
    [No Abstract]   [Full Text] [Related]  

  • 49. Treatment of psoriasis with etanercept in a patient with a history of primary B-cell lymphoma.
    Chong BF; Wong HK
    Clin Exp Dermatol; 2009 Jul; 34(5):e11-3. PubMed ID: 19040508
    [TBL] [Abstract][Full Text] [Related]  

  • 50. British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005.
    Smith CH; Anstey AV; Barker JN; Burden AD; Chalmers RJ; Chandler D; Finlay AY; Griffiths CE; Jackson K; McHugh NJ; McKenna KE; Reynolds NJ; Ormerod AD;
    Br J Dermatol; 2005 Sep; 153(3):486-97. PubMed ID: 16120132
    [No Abstract]   [Full Text] [Related]  

  • 51. [Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions].
    Paul C; Solignac M
    Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):13-5. PubMed ID: 20510165
    [No Abstract]   [Full Text] [Related]  

  • 52. Etanercept in severe, recalcitrant psoriasis: clinical response, safety profile and predictors of response based on a single institution's experience.
    Antoniou C; Dessinioti C; Stratigos A; Avgerinou G; Stavropoulos P; Katsambas A
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):979-82. PubMed ID: 19470056
    [No Abstract]   [Full Text] [Related]  

  • 53. Etanercept for the treatment of psoriasis in the elderly.
    Militello G; Xia A; Stevens SR; Van Voorhees AS
    J Am Acad Dermatol; 2006 Sep; 55(3):517-9. PubMed ID: 16908365
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A; Esposito M; Costanzo A; Chimenti S
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. QuantiFERON-TB Gold testing for tuberculosis in psoriasis patients commencing anti-tumour necrosis factor alpha therapy.
    Desai N; Raste Y; Cooke NT; Harland CC
    Br J Dermatol; 2008 May; 158(5):1137-8. PubMed ID: 18279462
    [No Abstract]   [Full Text] [Related]  

  • 56. [Analysis of lymphocyte populations in psoriatic plaques following inhibition of tumor necrosis factor alpha with etanercept].
    Mahiques L; Pitarch G; Sánchez-Carazo JL; Pérez-Ferriols A; Soriano CJ; Alegre V
    Actas Dermosifiliogr; 2007 Oct; 98(8):539-44. PubMed ID: 17919428
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Etanercept, a TNF antagonist for treatment for psoriatic arthritis and psoriasis.
    Mease PJ
    Skin Therapy Lett; 2003 Jan; 8(1):1-4. PubMed ID: 12728284
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute myelogenous leukemia in a patient receiving etanercept for psoriasis.
    Bachmeyer C; Thiolière B; Khosrotehrani K; Cattan E
    J Am Acad Dermatol; 2007 Jan; 56(1):169-70. PubMed ID: 17190640
    [No Abstract]   [Full Text] [Related]  

  • 59. Etanercept treatment for children and adolescents with plaque psoriasis.
    Paller AS; Siegfried EC; Langley RG; Gottlieb AB; Pariser D; Landells I; Hebert AA; Eichenfield LF; Patel V; Creamer K; Jahreis A;
    N Engl J Med; 2008 Jan; 358(3):241-51. PubMed ID: 18199863
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rapid onset of cutaneous squamous cell carcinoma of the penis in a patient with psoriasis on etanercept therapy.
    Fryrear RS; Wiggins AK; Sangueza O; Yosipovitch G
    J Am Acad Dermatol; 2004 Dec; 51(6):1026. PubMed ID: 15583608
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.